These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2790187)

  • 1. Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans.
    Dol F; Houin G; Rostin M; Montastruc JL; Dupouy D; Gianese F; Sie P; Boneu B
    Blood; 1989 Oct; 74(5):1577-82. PubMed ID: 2790187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers.
    Blardi P; Messa GL; Urso R; Di Perri T
    Int J Clin Pharmacol Res; 1993; 13(4):231-8. PubMed ID: 8150550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
    Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pharmacokinetics and pharmacodynamics of MF 701 dermatan sulfate administered by continuous intravenous infusion.
    Agnelli G; Cosmi B; Renga C; Federici F; Nenci GG; Houin G; Gianese F
    Thromb Haemost; 1990 Oct; 64(2):256-9. PubMed ID: 2270533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection.
    Dol F; Houin G; Dupouy D; Cadroy Y; Caranobe C; Gabaig AM; Mardiguian J; Sié P; Boneu B
    Thromb Haemost; 1988 Apr; 59(2):255-8. PubMed ID: 3388296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteers.
    Harenberg J; Jeschek M; Acker M; Malsch R; Huhle G; Heene DL
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):49-56. PubMed ID: 8845462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
    Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
    J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of intramuscular dermatan sulfate revisited : a single- and repeated-dose study in healthy volunteers.
    Saivin S; Cambus JP; Thalamas C; Lau G; Boneu B; Houin G; Gianese F
    Clin Drug Investig; 2003; 23(8):533-43. PubMed ID: 17535066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties.
    Dol F; Caranobe C; Dupouy D; Petitou M; Lormeau JC; Choay J; Sié P; Boneu B
    Thromb Res; 1988 Oct; 52(2):153-64. PubMed ID: 3194890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits.
    Saivin S; Caranobe C; Petitou M; Sie P; Lormeau JC; Level M; Crepon B; Houin G; Boneu B
    Br J Haematol; 1992 Apr; 80(4):509-13. PubMed ID: 1581235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers.
    Tripodi A; Moia M; Bottasso B; Tenconi PM; Gianese F; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):663-72. PubMed ID: 1926059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.
    Gianese F; Nurmohamed MT; Imbimbo BP; Büller HR; Berckmans RJ; Ten Cate JW
    Br J Clin Pharmacol; 1993 Mar; 35(3):335-9. PubMed ID: 8471416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of heparin and related polysaccharides.
    Boneu B; Dol F; Caranobe C; Sie P; Houin G
    Ann N Y Acad Sci; 1989; 556():282-91. PubMed ID: 2544127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E; Colombi M; Gianese F; Cortellaro M
    Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of dermatan polysulfates.
    Akiyama F; Seno N; Yoshida K
    Tohoku J Exp Med; 1982 Apr; 136(4):359-65. PubMed ID: 6808700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatan sulfate and the prevention of experimental venous thrombosis].
    Desnoyers P; Bara L; Samama M
    Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of a new low molecular weight dermatan sulphate (Desmin 370) on blood coagulation and fibrinolysis in healthy subjects.
    Legnani C; Palareti G; Biagi R; Ludovici S; Maggiore L; Milani MR; Coccheri S
    Eur J Clin Pharmacol; 1994; 47(3):247-52. PubMed ID: 7867677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variations.
    Rostin M; Montastruc JL; Houin G; D'Azemar P; Bayrou B; Boneu B
    Fundam Clin Pharmacol; 1990; 4(1):17-23. PubMed ID: 2160414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and biological activities of dermatan sulfate (Mediolanum MF701) in healthy human volunteers.
    Dawes J; Hodson BA; MacGregor IR; Pepper DS; Prowse CV
    Ann N Y Acad Sci; 1989; 556():292-303. PubMed ID: 2735660
    [No Abstract]   [Full Text] [Related]  

  • 20. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.